Research Article

The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada

Figure 3

Relative risk of health care resource utilization for (a) COPD therapy and (b) health care visits in patients experiencing ≥1 exacerbation (,288) versus no exacerbations (,259) (IDRR). CI, confidence interval; COPD, chronic obstructive pulmonary disease; ER, emergency room; FP/SAL, fluticasone propionate/salmeterol; HCU, health care resource utilization; ICS, inhaled corticosteroid; ICU, intensive care unit; IDRR, incidence density rate ratio; LABA, long-acting agonist; OCS, oral corticosteroid; SAAC, short-acting anticholinergic; SABA, short-acting agonist.
(a)
(b)